SEC Form 4 · accession 0001209191-18-016480

QUAKER CHEMICAL CORP · KWR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, CEO and President · Director

Period of report

Mar 1, 2018

Accepted (ET)

Mar 5, 2018 · 4:36 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000081362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Mar 1, 2018	S	1,250	$160.128	D	135,700	D
Common Stock	Mar 1, 2018	M	5,965	$87.30	A	141,665	D
Common Stock	Mar 1, 2018	F	4,630	$153.00	D	137,035	D
Common Stock	holding	—	—		—	2,164	I	By son
Common Stock	holding	—	—		—	33,884	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F3	$87.30	Mar 1, 2018	M	5,965	D	—	Feb 25, 2022	Common Stock	5,965	0	D

F1The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 30, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.10 to $161.05, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3The options for this grant vested in three annual installments: 5,966 shares on February 25, 2016; 5,966 shares on February 25, 2017; and 5,965 shares on February 25, 2018.